Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-14-023890
Filing Date
2014-04-21
Accepted
2014-04-21 17:10:44
Documents
1
Period of Report
2014-04-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 v375217_form4.html 4  
1 FORM 4 v375217_form4.xml 4 3946
  Complete submission text file 0001144204-14-023890.txt   5614
Mailing Address 155 GIBBS STREET SUITE 412 ROCKVILLE MD 20850
Business Address 155 GIBBS STREET SUITE 412 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Issuer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 27 HEARTHSTONE ROAD HOPKINTON MA 01748
Business Address
Ballantyne Charles Evan (Reporting) CIK: 0001371742 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12584 | Film No.: 14774435